Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012446

Director acquired 2,672 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-09-05 Other acquisition 10b5-1 +325 $1.71 $556 214,019 D
Krogulski Kenneth Director 2023-09-06 Other acquisition 10b5-1 +325 $1.68 $546 214,344 D
Krogulski Kenneth Director 2023-09-07 Other acquisition 10b5-1 +325 $1.71 $556 214,669 D
Krogulski Kenneth Director 2023-09-08 Other acquisition 10b5-1 +325 $1.71 $556 214,994 D
Krogulski Kenneth Director 2023-09-11 Other acquisition 10b5-1 +325 $1.74 $566 215,319 D
Krogulski Kenneth Director 2023-09-12 Other acquisition 10b5-1 +325 $1.79 $582 215,644 D
Krogulski Kenneth Director 2023-09-13 Other acquisition 10b5-1 +325 $1.86 $605 215,969 D
Krogulski Kenneth Director 2023-09-14 Other acquisition 10b5-1 +325 $1.87 $608 216,294 D
Krogulski Kenneth Director 2023-09-15 Other acquisition 10b5-1 +72 $1.82 $131 216,366 D
Loading xslF345X05/marketforms-62634.xml…